Clincosm LogoSign in Get a demo

head and neck squamous cell cancer

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

Recruiting
  • Head and Neck Squamous Cell Cancer
  • Toripalimab Injection
  • Cetuximab Solution for infusion
  • Shanghai, China
    Shanghai East Hospital
Dec 15, 2022

Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • +2 more
  • Miami, Florida
  • +8 more
Dec 2, 2022

Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

Completed
Has Results
  • Head and Neck Squamous Cell Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 24, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022

Head and Neck Squamous Cell Cancer Trial in United States (Cetuximab, BYL719, IMRT (Intensity-Modulated Radiation Therapy))

Completed
  • Head and Neck Squamous Cell Cancer
  • Basking Ridge, New Jersey
  • +5 more
Oct 22, 2021

Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)

Completed
Has Results
  • Head and Neck Squamous Cell Cancer
  • INO-3112
  • CELLECTRA™-5P
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 4, 2021

Head and Neck Squamous Cell Cancer Trial in Shreveport (Cetuximab)

Terminated
Has Results
  • Head and Neck Squamous Cell Cancer
  • Shreveport, Louisiana
    LSU Health Sciences Center
Sep 16, 2020

Head and Neck Squamous Cell Cancer Trial in Beijing (Sintilimab and Nab-paclitaxel)

Unknown status
  • Head and Neck Squamous Cell Cancer
  • Sintilimab and Nab-paclitaxel
  • Beijing, China
    Department of Medical Oncology, Cancer Hospital, Chinese Academy
Jul 16, 2019

Non-Small-Cell Lung Carcinoma, Head and Neck Squamous Cell Cancer, Pulmonary Disease, Chronic Obstructive Trial in Pittsburgh

Terminated
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • LIFE Bronchoscopy
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center of the University of Pittsburgh Medical Ce
Sep 12, 2018

Head and Neck Squamous Cell Cancer Trial in Philadelphia (Metformin)

Completed
  • Head and Neck Squamous Cell Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 18, 2016

Melanoma, Breast Cancer, Head and Neck Squamous Cell Cancer Trial in Pittsburgh (Vaccinia virus (vvDD-CDSR))

Completed
  • Melanoma
  • +5 more
  • Vaccinia virus (vvDD-CDSR)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Dec 23, 2015

Head and Neck Squamous Cell Cancer Trial in Nanjing (Raltitrexed, 5-fluorouracil, Cisplatin)

Unknown status
  • Head and Neck Squamous Cell Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jun 29, 2015

Head and Neck Squamous Cell Cancer Trial in Washington (Cisplatin, cetuximab, Radiation)

Terminated
Has Results
  • Head and Neck Squamous Cell Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprhensive Cancer Center
Sep 26, 2014

Head and Neck Squamous Cell Cancer Trial in Helsinki (Nutritional counselling)

Unknown status
  • Head and Neck Squamous Cell Cancer
  • Nutritional counselling
  • Helsinki, HUS, Finland
    Department of Otolaryngology - Head & Neck Surgery, Helsinki Uni
Jun 9, 2014

Head and Neck Cancer Screening and Serum Repository

Completed
  • Head and Neck Squamous Cell Cancer
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 4, 2012